LLYEli Lilly and CompanySigning up patients
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Nausea · Vomiting · Drug-Related Side Effects and Adverse Reactions · Neoplasms
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 204 (planned)
- Started
- Nov 28, 2025
- Main results expected
- Dec 2026
- Fully finished
- Feb 2027
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Proportion of Participants with a Complete Response (CR) in the Delayed Phase of CINV
Measured over: 24 to 120 hours after first chemotherapy infusion
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07169851 · record last updated 2026-11-04 · checked 2026-11-09 15:42 UTC